+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 2
Age: 18Years - 72Years
All Genders
ID02133196

Evaluating Autologous Tumor-Infiltrating Lymphocyte Therapy with Chemotherapy and Aldesleukin for Advanced Non-Small Cell Lung Cancer

Led by National Cancer Institute (NCI) · Updated on 2026-10-20

85

Participants Needed

1

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating a new therapy for adults aged 18 to 72 with advanced non-small cell lung cancer NSCLC who have tumors that can be removed. The study aims to see if specially selected tumor-fighting white blood cells, called Tumor Infiltrating Lymphocytes TIL, can shrink NSCLC tumors and to assess the safety of this treatment. This approach builds on previous experiences with TIL therapy in melanoma and investigates its use in metastatic NSCLC. Participants undergo several stages including initial evaluations with scans and lab tests, followed by surgery to remove a tumor for growing the TIL cells. Additional white blood cells may be collected through leukapheresis. After the cells are grown, patients receive a non-myeloablative lymphodepleting chemotherapy regimen with cyclophosphamide and fludarabine, then the TIL cells are infused intravenously, followed by either high-dose or low-dose aldesleukin. Hospitalization for about 4 weeks is required for treatment. During the study, participants have regular follow-ups with physical exams, lab tests, and scans every 1 to 3 months for the first year and then every 6 months to 1 year if tumors continue to shrink. The study measures tumor response rate after cell infusion at multiple time points up to 2 years and monitors treatment side effects and cell characteristics for up to 2 to 4 years. Total study participation may include several years of monitoring and care.

CONDITIONS

Brief Title

T Cell Receptor Immunotherapy for Patients With Metastatic Non-Small Cell Lung Cancer

Research Team

N

NCI SB Immunotherapy Recruitment Center

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here